TABLE 3.
Growth or no growth of Escherichia coli ATCC 25922 in the presence of peptide-antibiotic combinations
| Antibiotica | MICb (μg/ml) | Antibiotic concn (μg/ml) | Growthc |
||
|---|---|---|---|---|---|
| Compound 79 | Compound 33 | No peptide | |||
| PEN | 16 | 2d | + | + | + |
| ERY | 16 | 0.5e | − | + | + |
| FUS | 500 | 1f | − | − | + |
| NOV | 16 | 1g | − | − | + |
| RIF | 2 | 0.5e | − | − | + |
| VAN | 250 | 4h | + | + | + |
| No antibiotic | NAi | NA | + | + | + |
PEN, benzylpenicillin; ERY, erythromycin; FUS, fusidic acid; NOV, novobiocin; RIF, rifampin; VAN, vancomycin.
MICs of antibiotics individually.
Compounds 79 and 33 were tested at a concentration of 1 μM each. +, growth; −, no growth.
EUCAST generic breakpoint.
EUCAST breakpoints for Streptococcus spp.
EUCAST breakpoints for Staphylococcus spp.
Arbitrary breakpoint defined in the absence of any clinical breakpoint.
EUCAST breakpoint for Enterococcus spp.
NA, not applicable.